Loading
Life sciences · Journal article
Gut Microbes · September 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Oxazolidinones are critical last-resort antimicrobials against severe infections caused by Gram-positive bacteria, whereas mobile oxazolidinone resistance genes (MORGs, including cfr, optrA, poxtA) severely compromise their clinical efficacy. To date, most surveillance and mechanistic studies focusing on MORGs have focused on aerobic pathogens, while anaerobic commensal and opportunistic bacteria are largely overlooked as hidden resistance reservoirs, leading to critical knowledge gaps under the One Health framework. Here, we identified six MORG-carrying anaerobic gut bacteria belonging to four distinct genera. Notably, this is the first report on the identification of cfr (B) in Gram-negative bacteria and optrA in three previously unreported host species. Genomic dissection further confirmed diverse mobile genetic elements driving horizontal dissemination of MORGs across phylogenetically distant anaerobes. Multiple additional resistance genes coexisted with MORGs in these gut anaerobes. Our findings demonstrate that intestinal anaerobic bacteria constitute a neglected critical reservoir for clinically vital MORGs, highlighting an urgent need for strengthened antimicrobial resistance surveillance of anaerobes across animal and human hosts.